1CM
1492 Capital Management Portfolio holdings
AUM
$217M
1-Year Return
52.69%
This Quarter Return
+22.81%
1 Year Return
+52.69%
3 Year Return
+178.34%
5 Year Return
+433.82%
10 Year Return
+2,044.93%
AUM
$217M
AUM Growth
+$31.5M
(+17%)
Cap. Flow
+$574K
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
30.54%
Holding
128
New
17
Increased
30
Reduced
44
Closed
15
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$3.1M |
| 2 |
Jefferies Financial Group
JEF
|
$2.1M |
| 3 |
Meritage Homes
MTH
|
$2.09M |
| 4 |
AeroVironment
AVAV
|
$2.01M |
| 5 |
Lumentum
LITE
|
$1.93M |
Top Sells
| 1 |
Sterling Infrastructure
STRL
|
$6.31M |
| 2 |
Encompass Health
EHC
|
$5.89M |
| 3 |
Veritex Holdings
VBTX
|
$4.19M |
| 4 |
ATI
ATI
|
$2.7M |
| 5 |
DocGo
DCGO
|
$1.75M |
Sector Composition
| 1 | Technology | 27.38% |
| 2 | Industrials | 16.94% |
| 3 | Healthcare | 15.44% |
| 4 | Financials | 10.6% |
| 5 | Consumer Discretionary | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-496
| Closed | -$240K |
|
127
Astrana Health
ASTH
$1.37B
| – | – |
-26,860
| Closed | -$833K |
|
|
SYRS
128
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – |
-39,244
| Closed | -$1.18K |
|